The interplay of dendritic cell subsets in systemic lupus erythematosus

Immunology and Cell Biology

Volumn 80, Issue 5, 2002, Pages 484-488

  Palucka, A Karolina ^a   Banchereau, Jacques ^a   Blanco, Patrick ^a   Pascual, Virginia ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; DENDRITIC CELL; HUMAN; IMMUNITY; NONHUMAN; PATHOGENESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGENS, CD11C; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTE SUBSETS; CYTOKINES; DENDRITIC CELLS; HOMEOSTASIS; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MODELS, IMMUNOLOGICAL; MYELOID CELLS; T-LYMPHOCYTE SUBSETS;

EID: 0036380887     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2002.01112.x     Document Type: Review

References (40)

1. Kammer GM, Tsokos GC. Lupus: Molecular and Cellular Pathogenesis. Dallas: Humana Press, 1999.
2. Lahita RG. Systemic Lupus Erythematosus (3rd edn) Dallas: Academic Press, 1999.
3. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001; 15: 397.
4. Rozzo SJ, Allard JD, Choubey D, et al. Evidence for an Interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 2001; 15: 435.
5. Odendahl M, Jacobi A, Hansen A, et al. Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J. Immunol. 2000; 165: 5970.
6. Arce E, Jackson DG, Gill MA, Bennett LB, Banchereau J, Pascual V. Increased frequency of pre-germinal center B cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 2001; 167: 2361.
7. Banchereau J, Briere F, Caux C, et al. Immunobiology of den-dritic cells. Ann. Rev. Immunol. 2000; 18: 767.
8. Huang FP, Platt N, Wykes M, et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 2000; 191: 435.
9. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000; 191: 411.
10. Steinman RM, Nussenzweig MC. Inaugural Article: Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance. Proc. Natl Acad. Sci. USA 2002; 99: 351.
11. Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC. Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J. Immunol. 1996; 157: 1406.
12. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol. 2001; 19: 47.
13. O'Doherty U, Peng M, Gezelter S, et al. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994; 82: 487.
14. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997; 185: 1101.
15. Blom B, Ho S, Antonenko S, Liu YJ. Generation of interferon alpha-producing predendritic cell (Pre-DC) 2 from human CD34 (+) hematopoietic stem cells. J. Exp. Med. 2000; 192: 1785.
16. Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH. Id2 and Id3 inhibit development of CD34+ stem cells into pre-DC2 but not into pre-DC1: evidence for a lymphoid origin of pre-DC2. J. Exp. Med. 2000; 192.
17. Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood [In Process Citation]. Science 1999; 284: 1835.
18. Cella M, Jarrossay D, Facchetti F, et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce high levels of type I IFN. Nature Med. 1999.
19. Kadowaki N, Antonenko S, Lau JY, Liu Y. Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J. Exp. Med. 1999; 192: 219.
20. Caux C, Massacrier C, Vanbervliet B, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumour necrosis factor alpha. II. Functional analysis. Blood 1997; 90: 1458.
21. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science, 2001; 294: 1540.
22. Pulendran B, Banchereau J, Burkeholder S, et al. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsetsin vivo. J. Immunol. 2000; 165: 566.
23. Santini SM, Lapenta C, Logozzi M, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J. Exp. Med. 2000; 191: 1777.
24. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461.
25. Muller-Hermelink HK, Kaiserling E, Lennert K. [Pseudofollicu-lar nests of plasmacells (of a special type?) in paracortical pulp of human lymph nodes (author's transl)]. Virchows Arch. B. Cell Pathol. 1973; 14: 47.
26. Lennert K, Kaiserling E, Muller-Hermelink HK. Letter: T-associated plasma-cells. Lancet 1975; 1: 1031.
27. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982; 216: 429.
28. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J. Clin. Invest. 1990; 86: 69.
29. Williams RC Jr, Malone CC, Meyers C, Decker P, Muller S. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. J. Rheumatol. 2001; 28: 81.
30. Vallin H, Perers A, Alm GV, Ronnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 1999; 163: 6306.
31. Lin Q, Dong C, Cooper MD. Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 1998; 187: 79.
32. Binder D, Fehr J, Hengartner H, Zinkernagel RM. Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 1999; 185: 517.
33. Galibert L, Burdin N, de Saint-Vis B, et al. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 1996; 183: 77.
34. Moss J, Shor I, Woodrow D, Gresser I. Interferon-induced glomerular basement membrane and endothelial cell lesions in mice. An immunogold ultrastructural study of basement membrane components. Am. J. Pathol. 1988; 133: 557.
35. Gresser I, Maury C, Tovey M, Morel-Maroger L, Pontillon F. Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature 1976; 263: 420.
36. Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum. 2000; 43: 1431.
37. Foulis AK, Farquharson MA, Meager A. Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 1987; 2: 1423.
38. Funk J, Langeland T, Schrumpf E, Hanssen LE. Psoriasis induced by interferon-alpha. Br. J. Dermatol. 1991; 125: 463.
39. Ronnblom L, Alm GV. A pivotal role for the natural interferon alpha-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J. Exp. Med. 2001; 194: 59.
40. Dzionek A, Sohma Y, Nagafune J, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Medical 2001; 194: 1823.